Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
Open Access
- 21 August 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (18) , 18588-18596
Abstract
Background: Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML.Methods: We detected nine single nucleotide polymorphisms (SNPs) in immune checkpoint‐related genes, including PD1, LAG3, TIM3, and TIGIT in 285 AML inpatients and 324 healthy controls. SNP genotyping was performed on the MassARRAY platform. Furthermore, we analyzed the relationship between the susceptibility and prognosis of AML and the selected SNPs.Results: Our results showed that rs2227982 and rs10204525 in PD1 were significantly associated with susceptibility to AML after false discovery rate correction. PD1 rs10204525 also showed a significant correlation with the response to chemotherapy and risk stratification of AML. Importantly, the AA genotype of PD1 (rs2227982) under the recessive model showed a negative impact on AML prognosis independently.Conclusions: Our results indicate that PD1 SNPs are important for susceptibility and prognosis in AML, which may provide a new therapeutic target for AML patients.Keywords
Funding Information
- National Natural Science Foundation of China (81873425, 82070160, 82170182)
This publication has 39 references indexed in Scilit:
- Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blastsCancer Immunology, Immunotherapy, 2016
- Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapyCancer Letters, 2015
- Adverse Prognostic Impact of Abnormal Lesions Detected by Genome-Wide Single Nucleotide Polymorphism Array–Based Karyotyping Analysis in Acute Myeloid Leukemia With Normal KaryotypeJournal of Clinical Oncology, 2011
- Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemiaBlood, 2010
- Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic FactorJournal of Clinical Oncology, 2010
- Single Nucleotide Polymorphism in the Mutational Hotspot ofWT1Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- Single-nucleotide Polymorphisms in the p53 Signaling PathwayCold Spring Harbor Perspectives in Biology, 2009
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia modelBlood, 2009
- Acute Myeloid Leukemia: The Challenge of Capturing Disease VarietyHematology-American Society Hematology Education Program, 2008
- PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθFEBS Letters, 2004